纤维生素α的差异表达及其在骨关节炎发病过程中的潜在参与
Rajkamal Kumavat1,2, Vijay Kumar3, Sagarika Biswas4,5,6
1Council of Scientific &Industrial Research (CSIR) - Institute of Genomics & Integrative Biology, Mall Road, Delhi University Campus, 110007, Delhi, India.
Molecular biotechnology
|January 5, 2024
概括
纤维原蛋白α (FGA) 蛋白显示为骨关节炎 (OA) 的生物标志物具有前途. 血和突组织中FGA水平升高,与Toll-like受体4通路相关,可能有助于OA的诊断和监测.
科学领域:
- 生物化学 生化学
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 骨关节炎 (OA) 的特点是软骨和突组织的恶化.
- 目前对OA分子通路的理解有限,这阻碍了有效的诊断和治疗.
研究的目的:
- 为了确定骨关节炎的敏感和特定的蛋白质生物标志物.
- 阐明OA的潜在分子机制和病理生理学.
主要方法:
- 分析了150名OA患者和70名健康对照者的血样本.
- 使用西式涂抹,ELISA,免疫组织化学和免疫光学来验证蛋白质表达.
- 在外周血液单核细胞 (PBMC) 和突组织中对托尔类受体4 (TLR-4) 路径激活的研究.
主要成果:
- 纤维原蛋白α (FGA) 蛋白表达在OA血中显著更高 (p=0.0343).
- 在血中检测OA时,FGA表现出高灵敏度 (95.22%) 和特异性 (74%).
- 在OA突组织中观察到FGA沉积 (p=0.0073),并在PBMC和突组织中激活TLR-4通路.
结论:
- 纤维素阿尔法 (FGA) 在OA血,突组织和PBMC中显著表达.
- 通过TLR-4受体通路,FGA可能在关节炎的发病过程中发挥作用.
- FGA显示出作为骨关节炎的诊断和疾病监测工具的潜力.
更多相关视频
12:23Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model
Published on: April 24, 2020
19.7K
08:52Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness
Published on: March 18, 2022
3.0K
相关概念视频
The JAK-STAT Signaling Pathway
8.9K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.9K
TGF - β Signaling Pathway
7.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K
